Thirteen female cyclists/triathletes (mean peak VO 2 = 53.0 + 5.6 ml . 
INTRODUCTION
A number of physiological variables are reported to vary with fluctuations in female reproductive hormones seen throughout a menstrual cycle (18) .
However many findings remain largely inconclusive, probably due to the high intra-and inter-individual variability in estrogen and progesterone concentration, in conjunction with the pulsatile nature of the secretion of these hormones (17) . For this reason, the oral contraceptive (OC) cycle may provide a more stable environment to evaluate the acute effect of reproductive hormones on physiological variables and exercise performance in women.
Despite the widespread use of OC agents by female athletes (8) , OC users have not been included in the majority of menstrual cycle research and limited information exists regarding the influence of OC usage on the exercise responses of women. The majority of the literature has looked at sub-maximal aerobic exercise and has typically been performed on non-athletes (3, 9, 15) .
Predominantly, the physiological differences between OC users and nonusers, or pre and post OC treatment have been researched (1, 5, 11, 19, 21, 25) , with little data pertaining to variations within an OC cycle.
Of the studies that have investigated aerobic exercise parameters within an OC cycle most have found no variation as a result of acute hormonal change (7, 15, 20) . However, these findings may be limited because tests were conducted at times when the synthetic hormone intake would have been similar, as opposed to testing during the clearance times either pre-menstrual or menstrual, when there is a greater contrast in hormone levels. Further limitations of the existing OC research include small subject numbers, large variation in the timing of test days and the types of OC used.
In some studies the use of an OC has been associated with decreases in VO 2 max, ranging from 5 to 15%, following two to four months of OC use in both untrained subjects and trained athletes (10, 19, 25) . In addition, substrate metabolism has been found to vary with OC use. Most studies suggest that there is a slight reduction in carbohydrate metabolism during sub-maximal aerobic exercise with OC use, primarily due to a decreased dependence on glycogen and altered secretion rates of gluco-regulatory hormones (1,3,5, ,12,21) . Some studies have also reported increases in fat metabolism during exercise with OC use (5, 9, 16, 23) , whilst others demonstrated no difference (1, 25) . It is possible that the variation in test protocols, including exercise mode, duration and intensity has influenced these findings, as well as the use of different OC agents. For example, in one of the earlier studies (5) subjects used OC formulations that contained 50ug of estrogen, unlike the modern day combinations that contain 20-30ug of estrogen. Recent research (12) has demonstrated that estrogen and progesterone have opposing actions on substrate metabolism. The findings suggest that the ratio of these hormones (endogenous and/or exogenous) may be important in determining the impact of menstrual cycle or OC phase on athletic performance.
The purpose of this study was to examine whether endurance performance is affected by acute hormonal fluctuation within an OC cycle, in trained female athletes taking monophasic OC agents. The data should assist female athletes in making more informed decisions about the role of OC agents in manipulating the menstrual cycle, with a view to optimizing performance. It should also determine whether it is necessary to consider OC cycle phase for routine and research based scientific testing. We hypothesized that endurance performance would be optimal during the consumption phase of the OC cycle, as a result of a shift in substrate metabolism toward increased fat metabolism, and reduction in glycogen depletion and blood lactate accumulation.
METHODS
Thirteen trained (mean + SD peak VO 2 
Assessment of peak oxygen uptake
The test commenced at an initial workload of 50 W and subsequent 25 W increments were applied every 3 minutes until volitional fatigue. The methodology for the test, the assessment of oxygen uptake and lactate analysis was as described by Bishop, 1997 (4) .
Assessment of Endurance Performance
Following a standardized warm up, endurance performance was assessed by the calculated mean power output (W) produced by the participant during a 1h cycle test. The cyclists were instructed to produce the greatest power output possible throughout the test. For the initial eight minutes of exercise, power output was preset at the individual's lactate threshold (determined from the results of the incremental test) and thereafter the subject was free to alter pedal force, gears and cadence. They were provided with constant visual feedback of power output, pedal cadence, heart rate and elapsed time (4).
Each participant was permitted to ingest water ad libitum during the test, at two intervals between 20-25 min and 40-45 min.
Oxygen consumption
Throughout the test participants were fitted with a breathing valve (which was removed to permit ingestion of fluids between 20-25 min and 40-45min) and expired air was analyzed for O 2 and CO 2 concentrations using Ametek gas analyzers (SOV S-3A and COV CD3A respectively, Pittsburgh, USA) and ventilation (V I ) was measured using a turbine ventilometer (Morgan, Model 096, Kent, England). All equipment was calibrated pre and post-test in accordance with national laboratory standards requirements. Every 30s oxygen consumption (VO 2 ), ventilation (V E ), and ventilatory equivalent for oxygen consumption (V E /VO 2 ) were calculated and averaged.
Heart rate
Prior to the test, participants were fitted with a heart rate monitor (Polar Vantage NV, Polar Electro Oy, Finland). Data was continuously collected and stored for later analysis.
Capillary blood samples
Prior to commencement and every 10 min during the test, fingertip capillary blood samples were collected for subsequent blood lactate and blood gas analysis (ABL TM 700 Series, Radiometer Medical A/S, Copenhagen, Denmark).
Rating of perceived exertion
Every 5 min participants were asked to numerically rate the perceived intensity of exercise (RPE), on a Borg scale of numbers from 6-20.
Endogenous hormones
Prior to each performance test a resting blood sample was obtained, by routine venepuncture of an antecubital vein. Blood samples were centrifuged, stored in a freezer at -22°C and later analyzed for endogenous serum hormones estradiol and progesterone (PathWest, Laboratory Medicine, WA), using a one-step chemiluminescent competitive immunoassay (% CVestradiol 4.7, progesterone 5.6).
Statistics
Descriptive statistics (mean ± SD) were used to characterize the data. The measured variables were averaged over the 60 min (50 min for oxygen consumption data) and analyzed using a one-way within-subjects repeated measures ANOVA to determine any difference between the OC phases. For results that obtained or approached statistical significance (p < 0.10), planned comparisons were tested between particular phases of the repeated measures design (Statistica Version 5, '97 edition). For all tests, statistical significance was preset at p < 0.05.
RESULTS
For the endurance performance test, the mean, SD and range of results for measured variables, during each OC phase are presented in ).
Insert Table 2

DISCUSSION
The main purpose of this study was to determine whether endurance performance is affected by the acute hormonal variation seen within a monophasic OC cycle. Although the test selected was not sport specific, it was used because of its proven reliability (ICC 0.97, CV 2.7%, SEM 3.4W), whilst providing a valid reflection of endurance performance, as opposed to 'time to exhaustion tests', which may be more valid for the assessment of endurance capacity (4 ) is likely to be relatively small and may be within the typical error of measurement for this variable. It should also be acknowledged that whilst the measure of endurance performance used here has been deemed reliable (4), the reliability of blood lactate measures throughout the test has not been previously assessed. Given there was no corresponding difference in RER or blood glucose concentrations, within the parameters of the study it is difficult to attribute the variation in the lactate result to shifts in substrate metabolism.
In further contrast to the hypothesis, the change in blood lactate had no apparent effect upon fatigue or the athlete's ability to sustain power output throughout the performance test.
Despite no difference in endurance performance, some physiological parameters were not constant during the OC cycle. Mean V E was significantly higher during CONS (68. The effects of progesterone are thought to be centrally modulated and include an increased chemosensitivity to hypoxia and hypercapnia (13) . An increased ventilatory response and elevated V E /VO 2 during the luteal phase of a regular menstrual cycle (when progesterone levels are elevated), has been confirmed during sub maximal aerobic exercise in some studies (2, 24, 26) . Previous OC research has reported no within cycle ventilatory differences (7, 15, 20) .
However, the findings of these studies are limited because testing was conducted at two times when the synthetic hormone intake was similar (during ) may support the assessment of the withdrawal phase during two distinct phases.
Overall, there was no change in endurance performance (1-h cycle)
throughout an OC cycle in endurance trained female athletes. Therefore, female athletes taking a monophasic OC do not need to be concerned about the timing of their cycle with regards to optimised endurance performance and competition. Despite this finding, the cyclical variation in V E , V E /VO 2 and blood lactate should be considered when interpreting physiological test results. 
